Human monoclonal antibodies against human CXCR4
    1.
    发明授权
    Human monoclonal antibodies against human CXCR4 有权
    针对人CXCR4的人单克隆抗体

    公开(公告)号:US07138496B2

    公开(公告)日:2006-11-21

    申请号:US10360828

    申请日:2003-02-07

    IPC分类号: C07K16/00 C12P21/08

    摘要: Compositions are provided that comprise antibody against membrane proteins such as chemokine receptors. In particular, monoclonal human antibodies against human CXCR4 are provided that are capable of inhibiting HIV infection and chemotaxis in human breast cancer cells. The antibodies can be used as prophylactics or therapeutics to prevent and treat HIV infection and cancer, for screening drugs, and for diagnosing diseases or conditions associated with interactions with chemokine receptors.

    摘要翻译: 提供了包含针对膜蛋白如趋化因子受体的抗体的组合物。 特别地,提供能够抑制人乳腺癌细胞中的HIV感染和趋化性的针对人CXCR4的单克隆抗体。 抗体可用作预防或治疗以预防和治疗HIV感染和癌症,用于筛选药物,以及用于诊断与趋化因子受体相互作用相关的疾病或病症。